✦ LIBER ✦

PCV6 MODELED ACHIEVEMENT OF OPTIMAL LIPID VALUES WITH EXTENDED-RELEASE NIACIN/LOVASTATIN VERSUS SIMVASTATIN/EZETIMIBE COMBINATION THERAPY IN AT-RISK PATIENTS

✍ Scribed by EJ Stanek; R Quimbo; MJ Cziraky; SL Charland

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV19 RESIDUAL DYSLIPIDEMIA ON SIMVASTAT

✍ E Stanek; S Charland 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PCV66 MODELED ACHIEVEMENT OF OPTIMAL LIP

✍ SL Charland; R Quimbo; MJ Cziraky; RA Weathermon; EJ Stanek 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PCV15 COMBINED OPTIMAL LIPID VALUE GOAL

✍ S Balu; RA Quimbo; K Rodgers; RJ Simko; MJ Cziraky 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB